Chronic Migraine Epidemiology and Outcomes Study

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Allergan
ClinicalTrials.gov Identifier:
NCT01648530
First received: July 20, 2012
Last updated: July 23, 2012
Last verified: July 2012

July 20, 2012
July 23, 2012
July 2012
November 2013   (final data collection date for primary outcome measure)
Migraine Disability Assessment (MIDAS) [ Time Frame: 13 Months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01648530 on ClinicalTrials.gov Archive Site
Subject Quality of Life Questionnaire [ Time Frame: 13 Months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Chronic Migraine Epidemiology and Outcomes Study
Not Provided

This is a population internet-based study to characterize migraine clinical course and impact on family.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Subjects with chronic migraine

Migraine Disorders
Not Provided
Migraine
Subjects with migraine and household members
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
15000
November 2013
November 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • History of migraine
  • U.S. Member of Survey Panel
  • Household member of study participant
  • Ability to complete internet-based questionnaires

Exclusion Criteria:

  • No access to internet
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT01648530
GMA-BTX-12-470
No
Allergan
Allergan
Not Provided
Study Director: Medical Director Allergan
Allergan
July 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP